Scott Alan Peslak MD PhD
Sickle Cell & Other Anemias
Assistant Professor of Medicine, University of Pennsylvania
Join to View Full Profile
3400 Spruce St# HospitalPhiladelphia, PA 19104
Phone+1 267-303-6321
Fax+1 215-662-7919
Dr. Peslak is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Scott Peslak is a hematologist in Philadelphia, PA and is affiliated with the University of Pennsylvania. He received his MD/PhD from the University of Rochester School of Medicine and Dentistry and has been in practice 2 years. He specializes in sickle cell & other anemias and is experienced in sickle cell disease, thalassemias, and other red cell disorders. He has more than 15 publications and over 200 citations.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2016 - 2021- University of Pennsylvania Health SystemResidency, Internal Medicine, 2015 - 2016
- University of Pennsylvania Health SystemInternship, Internal Medicine, 2014 - 2015
University of Rochester School of Medicine and DentistryClass of 2014
Certifications & Licensure
PA State Medical License 2014 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Distribution of Gastrointestinal and Dietary Risk Factors Among U.S. Adults Classified as Having Iron Deficiency Anemia Across Diagnostic Thresholds.Omar Al Ta'ani, Bridget M Mayrer, Nicole M Luche, Shazia Mehmood Siddique, Scott A Peslak
American Journal of Hematology. 2026-08-01 - Delayed Recognition and Significant Morbidity in Adults with Non-Transfusion-Dependent Thalassemia.Aaron N Cheng, Scott A Peslak, Sujit Sheth, Farzana A Sayani, Ashutosh Lal
Blood Advances. 2026-06-18 - Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.Sujit Sheth, Ashutosh Lal, Abena Appiah-Kubi, Scott A Peslak, Noemi Toiber Temin
Blood Advances. 2026-06-04
Press Mentions
Philadelphia Health Providers and Patients Seek a New Treatment Roadmap for Sickle Cell Disease After Drug RecallOctober 10th, 2024- Innovations in Hemophilia, Sickle Cell Disease, and Thalassemia at Penn MedicineMarch 8th, 2026
- Sickle Cell Anemia: What’s New and What’s NextMarch 27th, 2026
Grant Support
- Mentored Clinical Scientist Research Career Development Award (K08)NIDDK2021–2026
- Doris Duke Charitable Foundation Physician Scientist FellowshipDoris Duke Charitable Foundation2020–2022
- Measey Foundation Physician Scientist Fellowship AwardUniversity of Pennsylvania2020–2021
- Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (T32)NHLBI2017–2020
- Ruth L. Kirschstein National Research Service Award for Individual Predoctoral MD/PhD Fellows (F30)NIDDK2010–2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
